Novozymes A/S (OTCMKTS:NVZMY) Short Interest Update

Novozymes A/S (OTCMKTS:NVZMY) was the target of a significant growth in short interest in November. As of November 30th, there was short interest totalling 500 shares, a growth of 150.0% from the November 15th total of 200 shares. Based on an average daily trading volume, of 32,300 shares, the days-to-cover ratio is presently 0.0 days.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on NVZMY shares. Citigroup cut Novozymes A/S from a “neutral” rating to a “sell” rating in a report on Thursday, October 17th. Berenberg Bank raised Novozymes A/S to a “strong-buy” rating in a research note on Tuesday, September 24th. Finally, Barclays raised Novozymes A/S to a “strong-buy” rating in a research note on Monday, November 18th.

Novozymes A/S Stock Down 0.4 %

OTCMKTS:NVZMY traded down $0.23 on Friday, hitting $58.66. The stock had a trading volume of 19,720 shares, compared to its average volume of 12,918. The company has a fifty day moving average price of $61.63 and a two-hundred day moving average price of $63.45. Novozymes A/S has a 1-year low of $49.99 and a 1-year high of $72.50. The stock has a market cap of $27.47 billion, a price-to-earnings ratio of 37.12, a PEG ratio of 3.87 and a beta of 0.87.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.